Ophthalmic Viscoelastic Devices (OVDs) Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Ophthalmic Viscoelastic Devices (OVDs) Market by Type (Cohesive Ophthalmic Viscoelastic Devices (OVD) and Dispersive Ophthalmic Viscoelastic Devices (OVD)), By Application (Vitreoretinal Surgery, Glaucoma Surgery, Cataract Surgery, and Corneal Transplantation), By End User (Hospitals, Ophthalmology Clinics, and Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Global Ophthalmic Viscoelastic Devices (OVDs) Market was valued at $2,341 million in 2020 and is anticipated to grow at $3,227 million by 2027 recording a CAGR of 4.14% during the forecast period 2021-2027. Ophthalmic Viscoelastic Devices (OVDs) Market in a variety of eye surgeries, including cataract surgery, glaucoma surgery, and others. These devices help to protect the fragile ocular tissues by producing pressure in the anterior chamber, compartmentalising inside the eye, and allowing patients to have a speedier and safer surgery with a faster recovery. Depending on the situation, ophthalmologists use a variety of ophthalmic instruments. As a result, ophthalmic viscoelastic devices serve a critical role in the treatment of various eye diseases during surgery all over the world. Ophthalmic viscoelastic devices (OVDs) are the medical devices that are used in the cataract surgery in order to create and maintain the space in the anterior chamber of the eye during phacoemulsification and implantation of an intraocular lens (IOL). There are various types of the ophthalmic viscoelastic devices such as dispersive ophthalmic viscoelastic device and cohesive ophthalmic viscoelastic device. Most of the ophthalmic viscoelastic devices (OVDs) contain sodium hyaluronate (NaHA) or hydroxypropyl methylcellulose (HPMC). The surge in government initiatives aimed at establishing rules to control the global increase in vision impairment is pressuring major manufacturers to release new ophthalmic products. Other factors that contribute to the growth of the Ophthalmic Viscoelastic Devices Market include an increase in the prevalence of cataracts and glaucoma, an increase in the number of eye procedures performed, and an increase in the geriatric population. The Ophthalmic Viscoelastic Devices Market is also expected to rise due to an increase in the adoption of viscoelastic devices around the world.

 


Global Ophthalmic Viscoelastic Devices (OVDs) Market

MARKET SUMMARY
-
4.14%
  • Study Period– 2021-2027
  • Base Year– 2020
  • CAGR–4.14%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Ophthalmic Viscoelastic Devices (OVDs) Market

  • Ophthalmic viscoelastic devices market is segmented based on the type, application, end user and Geography.
  • In July 2015, Rayner Surgical Group Limited (‘Rayner’), the pioneering manufacturer of intraocular lenses for cataract surgery, has acquired the ophthalmic cataract surgery business of Aptissen SA (Geneva, Switzerland)
  • Ophthalmic Viscoelastic Devices (OVDs) Market gives historical, current, and future market sizes (US$ Bn) of product type and distribution channel and geographic regions.
  • This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
  • In addition, the market report includes regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.
  • Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
  • Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers engaged in manufacturing and supply of Infant nutrition
Market Key Players
  • Johnson & Johnson
  • Alcon Laboratories Inc.
  • Bausch & Lomb
  • Carl Zeiss AG
  • Rayner Company
  • Bohus BioTech AB
  • Lifecore Biomedical LLC
Growth

Ophthalmic Viscoelastic Devices (OVDs) Market

Increase in the prevalence of eye diseases and rise in the number of cataract and glaucoma surgeries are driving the growth of ophthalmic viscoelastic devices (OVDs) market. The favorable reimbursement policies for surgeries using ophthalmic viscoelastic devices (OVDs) and strategic approach of the manufacturers help them sustain the growth and expansion in the market. The collaborations, mergers and acquisitions among vendors are helping to drive the R&D activities which are expected to create the market growth. However, the availability of alternate therapies, poor healthcare infrastructure, and the lack of awareness among the healthcare fraternity may hinder the growth of the ophthalmic viscoelastic devices (OVDs) market over the forecast period.


North-America Got Significant Share

Ophthalmic Viscoelastic Devices (OVDs) Market

Geographically, global ophthalmic viscoelastic devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North Americaophthalmic viscoelastic devices market growth driven by increase in the prevalence of eye diseases. The growing geriatric population and higher adoption of the newer technology expected to drive the market growth in the region. Falling in the second place is the European region. The growing awareness about the advanced treatments among the patient population and large disposable income is emerging markets in the region driving the market revenue growth. The Asia Pacific region is expected to be growing faster over the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015 to 2020) and forecast (2021 to 2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Ophthalmic Viscoelastic Devices (OVDs) Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Johnson & Johnson ((U.S)
  • Alcon Laboratories Inc. (Switzerland)
  • Bausch & Lomb (U.S)
  • Carl Zeiss AG (Germany)
  • Rayner Company (UK)
  • Bohus BioTech AB (Sweden)
  • Lifecore Biomedical LLC (U.S)

Description

Global Ophthalmic Viscoelastic Devices (OVDs) Market was valued at $2,341 million in 2020 and is anticipated to grow at $3,227 million by 2027 recording a CAGR of 4.14% during the forecast period 2021-2027. Ophthalmic Viscoelastic Devices (OVDs) Market in a variety of eye surgeries, including cataract surgery, glaucoma surgery, and others. These devices help to protect the fragile ocular tissues by producing pressure in the anterior chamber, compartmentalising inside the eye, and allowing patients to have a speedier and safer surgery with a faster recovery. Depending on the situation, ophthalmologists use a variety of ophthalmic instruments. As a result, ophthalmic viscoelastic devices serve a critical role in the treatment of various eye diseases during surgery all over the world. Ophthalmic viscoelastic devices (OVDs) are the medical devices that are used in the cataract surgery in order to create and maintain the space in the anterior chamber of the eye during phacoemulsification and implantation of an intraocular lens (IOL). There are various types of the ophthalmic viscoelastic devices such as dispersive ophthalmic viscoelastic device and cohesive ophthalmic viscoelastic device. Most of the ophthalmic viscoelastic devices (OVDs) contain sodium hyaluronate (NaHA) or hydroxypropyl methylcellulose (HPMC). The surge in government initiatives aimed at establishing rules to control the global increase in vision impairment is pressuring major manufacturers to release new ophthalmic products. Other factors that contribute to the growth of the Ophthalmic Viscoelastic Devices Market include an increase in the prevalence of cataracts and glaucoma, an increase in the number of eye procedures performed, and an increase in the geriatric population. The Ophthalmic Viscoelastic Devices Market is also expected to rise due to an increase in the adoption of viscoelastic devices around the world.

 

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX